Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate and a poor prognosis. To solve the above limitations of multiomics studies of metabolism in PDAC and optimize the prognosis of PDAC clinically, we demonstrated a 16-gene prognostic signature based on the metabolic path...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Wenchao, Mo, Shaocong, Wang, Yulin, Kawabata-Iwakawa, Reika, Zhang, Wei, Yang, Zongcheng, Sun, Chenyu, Tsushima, Yoshito, Xu, Huaxiang, Nakajima, Takahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997486/
https://www.ncbi.nlm.nih.gov/pubmed/35406597
http://dx.doi.org/10.3390/cancers14071825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997486/
https://www.ncbi.nlm.nih.gov/pubmed/35406597
http://dx.doi.org/10.3390/cancers14071825

Ejemplares similares